test44
https://www.cytel.com/blog/2019-blog-roundup
December 18, 2019
With only two weeks left for this fabulous year to end, we would like to thank all our blog subscribers and new readers..
Read article
test44
https://www.cytel.com/blog/impact-of-ai-on-clinical-development
December 10, 2019
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September..
Read article
test44
https://www.cytel.com/blog/advance-external-controls
August 23, 2019
In place of collecting data from patients recruited for a trial who have been assigned to the control or..
Read article
test44
https://www.cytel.com/blog/predictive-biomarker-signature-characterization
August 1, 2019
The term biomarker signature describes the behavior of a set of biomarkers that define a signature to maximize the..
Read article
test44
https://www.cytel.com/blog/opening-black-box-ai
May 7, 2019
Nowadays, it’s difficult to pick up a mainstream newspaper or read an industry publication without seeing reference..
Read article
test44
https://www.cytel.com/blog/biomarker-driven-strategies-drug-development
test44
https://www.cytel.com/blog/statistical-methods-challenges-rare-disease-development
February 28, 2019
In honor of Rare Disease Day 2019 we share a new Cytel podcast featuring Cytel Strategic Consultant Ursula Garczarek..
Read article
test44
https://www.cytel.com/blog/trends-in-data-science-effective-statistician
February 21, 2019
In 2018, Cytel ran a qualitative survey among biostatisticians and programmers on trends in data science and..
Read article
test44
https://www.cytel.com/blog/blog-data-science-report-2018
September 10, 2018
The biopharmaceutical and healthcare industries now collect more data than ever before due to advances in the variety..
Read article
